Skip to main content

Sigyn Therapeutics, Inc.

SIGY
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001642159

No open-market purchases or sales by Sigyn Therapeutics, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.35K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +1 vs. previous quarter
1
13F valueReported value at the end of Q2 2026
$1.35K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding SIGY, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding SIGY at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Sigyn Therapeutics, Inc. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Sigyn Therapeutics, Inc. insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Sigyn Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 1 holders
Institutions holding SIGY in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Howard Capital Management Group, LLC53,000$1.35K0.00%+53,000New